Kodiak Sciences Says Eye Disease Treatment Boosted Vision,Retina
Photographer: danchooalex/iStockphoto via Getty Images
This article is for subscribers only.
Kodiak Sciences says its eye disease treatment, KSI-301, showed strong improvements in vision and retinal anatomy were observed over 12 weeks across all three diseases under study.
The company cited results from its Phase Ib study of the use of the anti-VEGF antibody biopolymer conjugate to treat wet AMD, Diabetic Eye Disease and Retinal Vein Occlusion.